Estrella Immunopharma, Inc.: Form S-1/A, filed Jan 16, 2026
Filed with the SEC on Jan 16, 2026 and accepted by EDGAR at Jan 16, 2026, 17:08 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-26-005233. Last ingested by Listed: Nov 3, 2026, 11:58 ET. Listed shows no prices and gives no investment advice.